Jump to content

Optical coherence tomography angiography

Add links
From Wikipedia, the free encyclopedia

Optical coherence tomography angiography (OCTA)[1][2][3][4] is a non-invasive imaging technique based on optical coherence tomography (OCT) developed to visualize vascular networks in the human retina,[4][5][6][7][8][9] choroid,[10][11][12][13] skin[14] and various animal models.[15][16][17] OCTA may make use of speckle variance optical coherence tomography.

OCTA uses motion contrast between cross-sectional OCT scans (B-frames) to differentiate blood flow from static tissue, enabling imaging of vascular anatomy.[4][18] To correct for patient movement during scanning, bulk tissue changes in the axial direction are eliminated, ensuring that all detected changes are due to red blood cell movement.[18] This form of OCT requires a very high sampling density in order to achieve the resolution needed to detect the tiny capillaries found in the retina.[18][19] This has allowed OCTA to obtain detailed images of retinal vasculature in the human retina[20] and become widely used clinically to diagnose a variety of eye diseases, such as age related macular degeneration (AMD),[21] diabetic retinopathy (DR),[22][23] artery and vein occlusions, and glaucoma.[24][18]

Medical uses

[edit]

While conventional dye-based angiography is still the common gold standard, OCTA has been evaluated and used across many diseases.[4][5][25] OCTA was first introduced in clinical eyecare in 2014.[26]

OCTA has applications in several diseases, including leading causes of blindness such as glaucoma[24] and age-related macular degeneration.[27] In diabetic retinopathy (DR), OCTA was shown to resolve previously established markers of severe disease (i.e., vitreous proliferation). Moreover, OCTA was shown to provide a plethora of additional biomarkers including subclinical loss of vessel density.[28][29][30][31] Thus, OCTA may offer in future the potential to monitor the progression of DR at an earlier, pre-clinical state. Similarly, OCTA was shown to provide more refined information compared to dye-based angiography in other vascular occlusive diseases such as central (or branch) retinal vein occlusion.[32][33]

How it works

[edit]

OCTA detects moving particles (red blood cells) by comparing sequential B-scans at the same cross-sectional location. To simply put it, the backscattered light reflected back from static samples would remain the same over multiple B-scans while the backscattered light reflected back from moving samples would fluctuate. Multiple algorithms have been proposed and utilized to contrast such motion signals from static signals in various biological tissues.[34][35][36][3][37][38]

Calculating blood flow

[edit]

An algorithm developed by Jia et al.[1] is used to determine blood flow in the retina. The split-spectrum amplitude decorrelation angiography (SSADA) algorithm calculates the decorrelation in the reflected light that is detected by the OCT device.

The blood vessels are where the most decorrelation occurs allowing them to be visualized, while static tissue has low decorrelation values.[39] The equation takes into account fluctuations of the received signal amplitude or intensity over time. Greater fluctuations receive a greater decorrelation value and indicate more movement.

A significant challenge when trying to image the eye is patient movement and saccadic movement of the eye. Movement introduces a lot of noise into the signal making tiny vessels impossible to distinguish. One approach to decreasing the influence of movement on signal detection is to shorten the scanning time. A short scan time prevents too much patient movement during signal acquisition. With the development of Fourier-domain OCT, spectral-domain OCT, and swept source signal acquisition time was greatly improved making OCTA possible.[40] OCTA scan time is now around three seconds, however, saccadic eye movement still causes a low signal-to-noise ratio. This is where SSADA proves to be very advantageous as it is able to greatly improve SNR by averaging the decorrelation across the number of B-scans, making the microvasculature of the retina visible.[39]

History

[edit]

Initial efforts to measure blood flow using OCT utilized the Doppler effect.[41][42] By comparing the phase of successive A-mode scans, the velocity of blood flow can be determined via the Doppler equation. This was deemed Optical Doppler Tomography; the development of spectral domain OCT (SD-OCT) and swept-source OCT (SS-OCT) greatly improved scan times since this phase information was readily accessible. Still, Doppler techniques were fundamentally limited by bulk eye motion artefacts, especially as longer scan times became important for increasing sensitivity.[43] In the mid-2000s systems began compensating for bulk eye motion, which significantly reduced motion artefacts. Systems also began to measure the variance and power of the Doppler phase between successive A-mode and B-mode scans; later it was shown that successive B-mode scans must be corrected for motion and the phase variance data must be thresholded to remove bulk eye motion distortion.[43][2][44][45]

By 2012, split spectrum amplitude decorrelation was shown to be effective at increasing SNR and decreasing motion artefacts.[37] Commercial OCT-A devices also emerged around this time, beginning with the OptoVue AngioVue in 2014 (SD-OCT) and the Topcon Atlantis/Triton soon after (SS-OCT).[43]

Other angiography techniques

[edit]

The most common angiographic techniques were fluorescein (FA) or indocyanine green angiography (ICGA), which both involve the use of an injectable dye. Intravenous dye injection is time-consuming and can have adverse side effects. Furthermore, the edges of the capillaries can become blurred due to dye leakage and imaging of the retina can only be 2D when using this method.[40] With OCTA, dye injection is not needed making the imaging process faster and more comfortable while at the same time improving the quality of the image.

The current gold standards of angiography, fluorescein angiography (FA) and indocyanine green angiography (ICGA), both require dye to be injected.[46][47]

OCTA does not need dye but is susceptible to motion artefacts. The dyes used in FA and ICGA can cause nausea, vomiting, and general discomfort, and only have an effective lifetime on the order of a few minutes.[48]

From a physics perspective, both dye-based methods utilize the phenomenon of fluorescence. For FA, this corresponds to an excitation wavelength of blue (around 470 nm) and an emission wavelength near yellow (520 nm).[49] For IGCA, the newer method, the excitation wavelength is between 750 and 800 nm while emission occurs above 800 nm.[50]

References

[edit]
  1. ^ a b Jia Y, Tan O, Tokayer J, Potsaid B, Wang Y, Liu JJ, et al. (February 2012). "Split-spectrum amplitude-decorrelation angiography with optical coherence tomography". Optics Express. 20 (4): 4710–4725. Bibcode:2012OExpr..20.4710J. doi:10.1364/OE.20.004710. PMC 3381646. PMID 22418228.
  2. ^ a b Makita S, Hong Y, Yamanari M, Yatagai T, Yasuno Y (August 2006). "Optical coherence angiography". Optics Express. 14 (17): 7821–7840. Bibcode:2006OExpr..14.7821M. doi:10.1364/oe.14.007821. hdl:2241/108149. PMID 19529151.
  3. ^ a b Wang RK, Jacques SL, Ma Z, Hurst S, Hanson SR, Gruber A (April 2007). "Three dimensional optical angiography". Optics Express. 15 (7): 4083–4097. Bibcode:2007OExpr..15.4083W. doi:10.1364/OE.15.004083. PMID 19532651.
  4. ^ a b c d Jia Y, Bailey ST, Hwang TS, McClintic SM, Gao SS, Pennesi ME, et al. (May 2015). "Quantitative optical coherence tomography angiography of vascular abnormalities in the living human eye". Proceedings of the National Academy of Sciences of the United States of America. 112 (18): E2395–E2402. Bibcode:2015PNAS..112E2395J. doi:10.1073/pnas.1500185112. PMC 4426471. PMID 25897021.
  5. ^ a b Gao SS, Jia Y, Zhang M, Su JP, Liu G, Hwang TS, et al. (July 2016). "Optical Coherence Tomography Angiography". Investigative Ophthalmology & Visual Science. 57 (9): OCT27–OCT36. doi:10.1167/iovs.15-19043. PMC 4968919. PMID 27409483.
  6. ^ Hormel TT, Jia Y, Jian Y, Hwang TS, Bailey ST, Pennesi ME, et al. (January 2021). "Plexus-specific retinal vascular anatomy and pathologies as seen by projection-resolved optical coherence tomographic angiography". Progress in Retinal and Eye Research. 80: 100878. doi:10.1016/j.preteyeres.2020.100878. PMC 7855241. PMID 32712135.
  7. ^ Kashani AH, Lee SY, Moshfeghi A, Durbin MK, Puliafito CA (November 2015). "Optical Coherence Tomography Angiography of Retinal Venous Occlusion". Retina. 35 (11): 2323–2331. doi:10.1097/iae.0000000000000811. PMID 26457395. S2CID 26880837.
  8. ^ Spaide RF, Klancnik JM, Cooney MJ (January 2015). "Retinal vascular layers imaged by fluorescein angiography and optical coherence tomography angiography". JAMA Ophthalmology. 133 (1): 45–50. doi:10.1001/jamaophthalmol.2014.3616. PMID 25317632.
  9. ^ Gildea D (October 2019). "The diagnostic value of optical coherence tomography angiography in diabetic retinopathy: a systematic review". International Ophthalmology. 39 (10): 2413–2433. doi:10.1007/s10792-018-1034-8. PMID 30382465.
  10. ^ Camino A, Guo Y, You Q, Wang J, Huang D, Bailey ST, Jia Y (October 2019). "Detecting and measuring areas of choriocapillaris low perfusion in intermediate, non-neovascular age-related macular degeneration". Neurophotonics. 6 (4): 041108. doi:10.1117/1.NPh.6.4.041108. PMC 6739623. PMID 31528658.
  11. ^ You QS, Chan JC, Ng AL, Choy BK, Shih KC, Cheung JJ, et al. (November 2019). "Macular Vessel Density Measured With Optical Coherence Tomography Angiography and Its Associations in a Large Population-Based Study". Investigative Ophthalmology & Visual Science. 60 (14): 4830–4837. doi:10.1167/iovs.19-28137. PMID 31747685. S2CID 208215569.
  12. ^ Levison AL, Baynes KM, Lowder CY, Kaiser PK, Srivastava SK (May 2017). "Choroidal neovascularisation on optical coherence tomography angiography in punctate inner choroidopathy and multifocal choroiditis". The British Journal of Ophthalmology. 101 (5): 616–622. doi:10.1136/bjophthalmol-2016-308806. PMID 27539089. S2CID 29133966.
  13. ^ Chu Z, Weinstein JE, Wang RK, Pepple KL (October 2020). "Quantitative Analysis of the Choriocapillaris in Uveitis Using En Face Swept-Source Optical Coherence Tomography Angiography". American Journal of Ophthalmology. 218: 17–27. doi:10.1016/j.ajo.2020.05.006. PMC 7529782. PMID 32413411.
  14. ^ Xu J, Song S, Men S, Wang RK (November 2017). "Long ranging swept-source optical coherence tomography-based angiography outperforms its spectral-domain counterpart in imaging human skin microcirculations". Journal of Biomedical Optics. 22 (11): 1–11. Bibcode:2017JBO....22k6007X. doi:10.1117/1.jbo.22.11.116007. PMC 5712670. PMID 29185292.
  15. ^ Fischer MD, Huber G, Beck SC, Tanimoto N, Muehlfriedel R, Fahl E, et al. (October 2009). "Noninvasive, in vivo assessment of mouse retinal structure using optical coherence tomography". PLOS ONE. 4 (10): e7507. Bibcode:2009PLoSO...4.7507F. doi:10.1371/journal.pone.0007507. PMC 2759518. PMID 19838301.
  16. ^ Merkle CW, Zhu J, Bernucci MT, Srinivasan VJ (November 2019). "Dynamic Contrast Optical Coherence Tomography reveals laminar microvascular hemodynamics in the mouse neocortex in vivo". NeuroImage. 202: 116067. doi:10.1016/j.neuroimage.2019.116067. PMC 6819266. PMID 31394180.
  17. ^ Chen S, Liu Q, Shu X, Soetikno B, Tong S, Zhang HF (September 2016). "Imaging hemodynamic response after ischemic stroke in mouse cortex using visible-light optical coherence tomography". Biomedical Optics Express. 7 (9): 3377–3389. doi:10.1364/boe.7.003377. PMC 5030017. PMID 27699105.
  18. ^ a b c d de Carlo TE, Romano A, Waheed NK, Duker JS (April 2015). "A review of optical coherence tomography angiography (OCTA)". International Journal of Retina and Vitreous. 1 (1): 5. doi:10.1186/s40942-015-0005-8. PMC 5066513. PMID 27847598.
  19. ^ Drexler W, Liu M, Kumar A, Kamali T, Unterhuber A, Leitgeb RA (2014). "Optical coherence tomography today: speed, contrast, and multimodality". Journal of Biomedical Optics. 19 (7): 071412. Bibcode:2014JBO....19g1412D. doi:10.1117/1.jbo.19.7.071412. PMID 25079820.
  20. ^ Campbell JP, Zhang M, Hwang TS, Bailey ST, Wilson DJ, Jia Y, Huang D (February 2017). "Detailed Vascular Anatomy of the Human Retina by Projection-Resolved Optical Coherence Tomography Angiography". Scientific Reports. 7 (1): 42201. Bibcode:2017NatSR...742201C. doi:10.1038/srep42201. PMC 5301488. PMID 28186181.
  21. ^ Jia Y, Bailey ST, Wilson DJ, Tan O, Klein ML, Flaxel CJ, et al. (July 2014). "Quantitative optical coherence tomography angiography of choroidal neovascularization in age-related macular degeneration". Ophthalmology. 121 (7): 1435–1444. doi:10.1016/j.ophtha.2014.01.034. PMC 4082740. PMID 24679442.
  22. ^ Hwang TS, Jia Y, Gao SS, Bailey ST, Lauer AK, Flaxel CJ, et al. (November 2015). "Optical Coherence Tomography Angiography Features of Diabetic Retinopathy". Retina. 35 (11): 2371–2376. doi:10.1097/IAE.0000000000000716. PMC 4623938. PMID 26308529.
  23. ^ Hwang TS, Gao SS, Liu L, Lauer AK, Bailey ST, Flaxel CJ, et al. (April 2016). "Automated Quantification of Capillary Nonperfusion Using Optical Coherence Tomography Angiography in Diabetic Retinopathy". JAMA Ophthalmology. 134 (4): 367–373. doi:10.1001/jamaophthalmol.2015.5658. PMC 4978127. PMID 26795548.
  24. ^ a b Jia Y, Wei E, Wang X, Zhang X, Morrison JC, Parikh M, et al. (July 2014). "Optical coherence tomography angiography of optic disc perfusion in glaucoma". Ophthalmology. 121 (7): 1322–1332. doi:10.1016/j.ophtha.2014.01.021. PMC 4082728. PMID 24629312.
  25. ^ Kashani AH, Chen CL, Gahm JK, Zheng F, Richter GM, Rosenfeld PJ, et al. (September 2017). "Optical coherence tomography angiography: A comprehensive review of current methods and clinical applications". Progress in Retinal and Eye Research. 60: 66–100. doi:10.1016/j.preteyeres.2017.07.002. PMC 5600872. PMID 28760677.
  26. ^ Spaide RF, Fujimoto JG, Waheed NK, Sadda SR, Staurenghi G (May 2018). "Optical coherence tomography angiography". Progress in Retinal and Eye Research. 64: 1–55. doi:10.1016/j.preteyeres.2017.11.003. PMC 6404988. PMID 29229445.
  27. ^ Jia, Yali; Bailey, Steven T.; Wilson, David J.; Tan, Ou; Klein, Michael L.; Flaxel, Christina J.; Potsaid, Benjamin; Liu, Jonathan J.; Lu, Chen D.; Kraus, Martin F.; Fujimoto, James G.; Huang, David (2014-07). "Quantitative Optical Coherence Tomography Angiography of Choroidal Neovascularization in Age-Related Macular Degeneration". Ophthalmology. 121 (7): 1435–1444. doi:10.1016/j.ophtha.2014.01.034. PMC 4082740. PMID 24679442.
  28. ^ Papakostas TD, Kiss S (August 2018). "Optical Coherence Tomography Angiography to Evaluate Ischemia in Diabetic Eyes". JAMA Ophthalmology. 136 (8): 936–937. doi:10.1001/jamaophthalmol.2018.2256. PMID 29902300. S2CID 49213827.
  29. ^ Wang B, Camino A, Pi S, Guo Y, Wang J, Huang D, et al. (July 2019). "Three-dimensional structural and angiographic evaluation of foveal ischemia in diabetic retinopathy: method and validation". Biomedical Optics Express. 10 (7): 3522–3532. doi:10.1364/BOE.10.003522. PMC 6640826. PMID 31360604.
  30. ^ Al-Sheikh M, Akil H, Pfau M, Sadda SR (July 2016). "Swept-Source OCT Angiography Imaging of the Foveal Avascular Zone and Macular Capillary Network Density in Diabetic Retinopathy". Investigative Ophthalmology & Visual Science. 57 (8): 3907–3913. doi:10.1167/iovs.16-19570. PMID 27472076.
  31. ^ Freiberg FJ, Pfau M, Wons J, Wirth MA, Becker MD, Michels S (June 2016). "Optical coherence tomography angiography of the foveal avascular zone in diabetic retinopathy". Graefe's Archive for Clinical and Experimental Ophthalmology. 254 (6): 1051–1058. doi:10.1007/s00417-015-3148-2. PMC 4884570. PMID 26338819.
  32. ^ Wons J, Pfau M, Wirth MA, Freiberg FJ, Becker MD, Michels S (2016). "Optical Coherence Tomography Angiography of the Foveal Avascular Zone in Retinal Vein Occlusion". Ophthalmologica. Journal International d'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde. 235 (4): 195–202. doi:10.1159/000445482. PMID 27160007. S2CID 22808467.
  33. ^ Tang W, Guo J, Zhuang X, Zhang T, Wang L, Wang K, et al. (February 2021). "Wide-Field Swept-Source Optical Coherence Tomography Angiography Analysis of the Periarterial Capillary-Free Zone in Branch Retinal Vein Occlusion". Translational Vision Science & Technology. 10 (2): 9. doi:10.1167/tvst.10.2.9. PMC 7881276. PMID 34003897.
  34. ^ Enfield J, Jonathan E, Leahy M (April 2011). "In vivo imaging of the microcirculation of the volar forearm using correlation mapping optical coherence tomography (cmOCT)". Biomedical Optics Express. 2 (5): 1184–1193. doi:10.1364/boe.2.001184. PMC 3087575. PMID 21559130.
  35. ^ Barton J, Stromski S (July 2005). "Flow measurement without phase information in optical coherence tomography images". Optics Express. 13 (14): 5234–5239. Bibcode:2005OExpr..13.5234B. doi:10.1364/OPEX.13.005234. PMID 19498514.
  36. ^ Fingler J, Zawadzki RJ, Werner JS, Schwartz D, Fraser SE (November 2009). "Volumetric microvascular imaging of human retina using optical coherence tomography with a novel motion contrast technique". Optics Express. 17 (24): 22190–22200. Bibcode:2009OExpr..1722190F. doi:10.1364/OE.17.022190. PMC 2791341. PMID 19997465.
  37. ^ a b Jia Y, Tan O, Tokayer J, Potsaid B, Wang Y, Liu JJ, et al. (February 2012). "Split-spectrum amplitude-decorrelation angiography with optical coherence tomography". Optics Express. 20 (4): 4710–4725. Bibcode:2012OExpr..20.4710J. doi:10.1364/oe.20.004710. hdl:1721.1/73109. PMC 3381646. PMID 22418228. S2CID 13838091.
  38. ^ Ryu G, Park D, Lim J, van Hemert J, Sagong M (May 2021). "Macular Microvascular Changes and Their Correlation With Peripheral Nonperfusion in Branch Retinal Vein Occlusion". American Journal of Ophthalmology. 225: 57–68. doi:10.1016/j.ajo.2020.12.026. PMID 33412121. S2CID 231192745.
  39. ^ a b Koustenis A, Harris A, Gross J, Januleviciene I, Shah A, Siesky B (January 2017). "Optical coherence tomography angiography: an overview of the technology and an assessment of applications for clinical research". The British Journal of Ophthalmology. 101 (1): 16–20. doi:10.1136/bjophthalmol-2016-309389. PMID 27707691. S2CID 11456379.
  40. ^ a b Gao SS, Jia Y, Zhang M, Su JP, Liu G, Hwang TS, et al. (July 2016). "Optical Coherence Tomography Angiography". Investigative Ophthalmology & Visual Science. 57 (9): OCT27–OCT36. doi:10.1167/iovs.15-19043. PMC 4968919. PMID 27409483.
  41. ^ Izatt JA, Kulkarni MD, Yazdanfar S, Barton JK, Welch AJ (September 1997). "In vivo bidirectional color Doppler flow imaging of picoliter blood volumes using optical coherence tomography". Optics Letters. 22 (18): 1439–1441. Bibcode:1997OptL...22.1439I. doi:10.1364/ol.22.001439. PMID 18188263.
  42. ^ Chen Z, Milner TE, Srinivas S, Wang X, Malekafzali A, van Gemert MJ, Nelson JS (July 1997). "Noninvasive imaging of in vivo blood flow velocity using optical Doppler tomography". Optics Letters. 22 (14): 1119–1121. Bibcode:1997OptL...22.1119C. doi:10.1364/ol.22.001119. PMID 18185770. S2CID 30205866.
  43. ^ a b c Spaide RF, Fujimoto JG, Waheed NK, Sadda SR, Staurenghi G (May 2018). "Optical coherence tomography angiography". Progress in Retinal and Eye Research. 64: 1–55. doi:10.1016/j.preteyeres.2017.11.003. PMC 6404988. PMID 29229445.
  44. ^ Fingler J, Zawadzki RJ, Werner JS, Schwartz D, Fraser SE (November 2009). "Volumetric microvascular imaging of human retina using optical coherence tomography with a novel motion contrast technique". Optics Express. 17 (24): 22190–22200. Bibcode:2009OExpr..1722190F. doi:10.1364/oe.17.022190. PMC 2791341. PMID 19997465.
  45. ^ Wang RK, Jacques SL, Ma Z, Hurst S, Hanson SR, Gruber A (April 2007). "Three dimensional optical angiography". Optics Express. 15 (7): 4083–4097. Bibcode:2007OExpr..15.4083W. doi:10.1364/OE.15.004083. PMID 19532651.
  46. ^ Gass JD, Sever RJ, Sparks D, Goren J (October 1967). "A combined technique of fluorescein funduscopy and angiography of the eye". Archives of Ophthalmology. 78 (4): 455–461. doi:10.1001/archopht.1967.00980030457009. PMID 6046840.
  47. ^ Slakter JS, Yannuzzi LA, Guyer DR, Sorenson JA, Orlock DA (June 1995). "Indocyanine-green angiography". Current Opinion in Ophthalmology. 6 (3): 25–32. doi:10.1097/00055735-199506000-00005. PMID 10151085. S2CID 43888613.
  48. ^ Yannuzzi LA, Rohrer KT, Tindel LJ, Sobel RS, Costanza MA, Shields W, Zang E (May 1986). "Fluorescein angiography complication survey". Ophthalmology. 93 (5): 611–617. doi:10.1016/s0161-6420(86)33697-2. PMID 3523356.
  49. ^ "Fluorescein Angiography". American Academy of Ophthalmolog. Archived from the original on 27 May 2016.
  50. ^ Alander JT, Kaartinen I, Laakso A, Pätilä T, Spillmann T, Tuchin VV, et al. (2012). "A review of indocyanine green fluorescent imaging in surgery". International Journal of Biomedical Imaging. 2012: 940585. doi:10.1155/2012/940585. PMC 3346977. PMID 22577366.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Optical_coherence_tomography_angiography&oldid=1239327774"